Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo
- PMID:10945827
Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo
Abstract
The mechanisms underlying the neuroprotective effects of the group II metabotropic glutamate receptor (mGluR) agonist LY379268 were investigated in a gerbil model of global ischemia. LY379268 (10 mg/kg i.p.) 30 or 60 min after 5-min bilateral carotid artery occlusion (BCAO) attenuated the ischemia-induced hyperactivity and provided protection in the CA1 hippocampal cells. This neuroprotective effect was maintained (P <.001) when histological analysis was performed 14 and 28 days after BCAO. Furthermore, 24- or 48-h pretreatment with LY379268, 10 mg/kg i.p., before 5-min BCAO markedly reduced (P <.001 and P <.05, respectively) the damage to CA1 hippocampal neurons. This result is consistent with the induction of neuroprotective factors or a very long brain half-life. To study the possible induction of neuroprotective factors as contributing to this action of LY379268, brains were examined for expression of neurotrophic factors. Results indicated that LY379268 (10 mg/kg i.p.) failed to alter the expression of transforming growth factor-beta, brain-derived neurotrophic factor, nerve growth factor, and basic fibroblast growth factor in the hippocampal regions of brains taken from gerbils sacrificed at 6, 24, 72, and 120 h postinjection. The new group II mGlu antagonist, LY341495, administered 1 h before 5-min BCAO, attenuated the neuroprotective effect of LY379268 administered 24 h before 5-min BCAO. Complementary pharmacokinetic studies showed that a significant receptor-active concentration persisted in the brain 24 h after LY379268 10 mg/kg i.p. We conclude that group II mGluR occupancy, rather than induction of neuroprotective factors, explains the long-lasting neuroprotective effect of LY379268 in the gerbil model of global ischemia.
Similar articles
- LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia.Bond A, Ragumoorthy N, Monn JA, Hicks CA, Ward MA, Lodge D, O'Neill MJ.Bond A, et al.Neurosci Lett. 1999 Oct 8;273(3):191-4. doi: 10.1016/s0304-3940(99)00663-1.Neurosci Lett. 1999.PMID:10515191
- Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain.Di Liberto V, Bonomo A, Frinchi M, Belluardo N, Mudò G.Di Liberto V, et al.Neuroscience. 2010 Feb 3;165(3):863-73. doi: 10.1016/j.neuroscience.2009.11.012. Epub 2009 Nov 10.Neuroscience. 2010.PMID:19909793
- Protection of neonatal rat brain from hypoxic-ischemic injury by LY379268, a Group II metabotropic glutamate receptor agonist.Cai Z, Xiao F, Fratkin JD, Rhodes PG.Cai Z, et al.Neuroreport. 1999 Dec 16;10(18):3927-31. doi: 10.1097/00001756-199912160-00037.Neuroreport. 1999.PMID:10716235
- The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268.Imre G.Imre G.CNS Drug Rev. 2007 Winter;13(4):444-64. doi: 10.1111/j.1527-3458.2007.00024.x.CNS Drug Rev. 2007.PMID:18078428Free PMC article.Review.
- [Apoptosis in neuronal structures and the role of neurotrophic growth factors. Biochemical mechanisms of brain derived peptide preparations].Gomazkov OA.Gomazkov OA.Zh Nevrol Psikhiatr Im S S Korsakova. 2002;(Suppl 7):17-21.Zh Nevrol Psikhiatr Im S S Korsakova. 2002.PMID:12747095Review.Russian.
Cited by
- Genetic Deletion of mGlu3 Metabotropic Glutamate Receptors Amplifies Ischemic Brain Damage and Associated Neuroinflammation in Mice.Mastroiacovo F, Zinni M, Mascio G, Bruno V, Battaglia G, Pansiot J, Imbriglio T, Mairesse J, Baud O, Nicoletti F.Mastroiacovo F, et al.Front Neurol. 2021 Jun 17;12:668877. doi: 10.3389/fneur.2021.668877. eCollection 2021.Front Neurol. 2021.PMID:34220677Free PMC article.
- Pretreatment with mGluR2 or mGluR3 Agonists Reduces Apoptosis Induced by Hypoxia-Ischemia in Neonatal Rat Brains.Bratek-Gerej E, Bronisz A, Ziembowicz A, Salinska E.Bratek-Gerej E, et al.Oxid Med Cell Longev. 2021 Mar 6;2021:8848015. doi: 10.1155/2021/8848015. eCollection 2021.Oxid Med Cell Longev. 2021.PMID:33763176Free PMC article.
- Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.Halberstadt AL, van der Zee JVF, Chatha M, Geyer MA, Powell SB.Halberstadt AL, et al.Psychopharmacology (Berl). 2019 Feb;236(2):821-830. doi: 10.1007/s00213-018-5118-y. Epub 2018 Nov 17.Psychopharmacology (Berl). 2019.PMID:30448990Free PMC article.
- Physiological activation of mGlu5 receptors supports the ion channel function of NMDA receptors in hippocampal LTD induction in vivo.O'Riordan KJ, Hu NW, Rowan MJ.O'Riordan KJ, et al.Sci Rep. 2018 Mar 13;8(1):4391. doi: 10.1038/s41598-018-22768-x.Sci Rep. 2018.PMID:29535352Free PMC article.
- Metabotropic Glutamate Receptors Protect Oligodendrocytes from Acute Ischemia in the Mouse Optic Nerve.Butt AM, Vanzulli I, Papanikolaou M, De La Rocha IC, Hawkins VE.Butt AM, et al.Neurochem Res. 2017 Sep;42(9):2468-2478. doi: 10.1007/s11064-017-2220-1. Epub 2017 Apr 1.Neurochem Res. 2017.PMID:28365868Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Other Literature Sources
Miscellaneous